647 related articles for article (PubMed ID: 26619118)
21. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
[TBL] [Abstract][Full Text] [Related]
22. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
[TBL] [Abstract][Full Text] [Related]
23. Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons.
Yang WN; Ma KG; Qian YH; Zhang JS; Feng GF; Shi LL; Zhang ZC; Liu ZH
Int J Biochem Cell Biol; 2015 Jul; 64():252-64. PubMed ID: 25936756
[TBL] [Abstract][Full Text] [Related]
24. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Zhu D; Su Y; Fu B; Xu H
Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
[TBL] [Abstract][Full Text] [Related]
25. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
Lee J; Lee H; Lee H; Shin M; Shin MG; Seo J; Lee EJ; Park SA; Park S
Nat Commun; 2023 Dec; 14(1):8463. PubMed ID: 38123547
[TBL] [Abstract][Full Text] [Related]
26. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.
Deane R; Sagare A; Hamm K; Parisi M; LaRue B; Guo H; Wu Z; Holtzman DM; Zlokovic BV
J Neurosci; 2005 Dec; 25(50):11495-503. PubMed ID: 16354907
[TBL] [Abstract][Full Text] [Related]
27. Ketone Bodies Promote Amyloid-β
Versele R; Corsi M; Fuso A; Sevin E; Businaro R; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023814
[TBL] [Abstract][Full Text] [Related]
28. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
[TBL] [Abstract][Full Text] [Related]
29. Neuronal clearance of amyloid-β by endocytic receptor LRP1.
Kanekiyo T; Cirrito JR; Liu CC; Shinohara M; Li J; Schuler DR; Shinohara M; Holtzman DM; Bu G
J Neurosci; 2013 Dec; 33(49):19276-83. PubMed ID: 24305823
[TBL] [Abstract][Full Text] [Related]
30. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
31. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.
Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EA
J Neurochem; 2010 Dec; 115(5):1077-89. PubMed ID: 20854368
[TBL] [Abstract][Full Text] [Related]
32. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
33. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
[TBL] [Abstract][Full Text] [Related]
34. Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice.
Chen F; Dong RR; Zhong KL; Ghosh A; Tang SS; Long Y; Hu M; Miao MX; Liao JM; Sun HB; Kong LY; Hong H
Neuropharmacology; 2016 Feb; 101():123-36. PubMed ID: 26211973
[TBL] [Abstract][Full Text] [Related]
35. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
36. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alemi M; Silva SC; Santana I; Cardoso I
CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
[TBL] [Abstract][Full Text] [Related]
37. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
Paganetti P; Antoniello K; Devraj K; Toni N; Kieran D; Madani R; Pihlgren M; Adolfsson O; Froestl W; Schrattenholz A; Liebner S; Havas D; Windisch M; Cirrito JR; Pfeifer A; Muhs A
J Alzheimers Dis; 2014; 38(4):767-86. PubMed ID: 24072071
[TBL] [Abstract][Full Text] [Related]
38. PCSK9 acts as a key regulator of Aβ clearance across the blood-brain barrier.
Mazura AD; Ohler A; Storck SE; Kurtyka M; Scharfenberg F; Weggen S; Becker-Pauly C; Pietrzik CU
Cell Mol Life Sci; 2022 Mar; 79(4):212. PubMed ID: 35344086
[TBL] [Abstract][Full Text] [Related]
39. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.
Deane R; Wu Z; Sagare A; Davis J; Du Yan S; Hamm K; Xu F; Parisi M; LaRue B; Hu HW; Spijkers P; Guo H; Song X; Lenting PJ; Van Nostrand WE; Zlokovic BV
Neuron; 2004 Aug; 43(3):333-44. PubMed ID: 15294142
[TBL] [Abstract][Full Text] [Related]
40. Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.
Kitazawa M; Hsu HW; Medeiros R
Toxicol Sci; 2016 Jul; 152(1):194-204. PubMed ID: 27122238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]